Table 3 Changes of fluid status and cumulative fluid balance over 3 days and outcomes (n = 70)

From: Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide measurement

Fluid status before CRRT		Fluid status 3 days later				Total death, n (%)
Fluid status before CRRT		Type 1	Type 2	Type 3	Type 4	Total death, n (%)
Type 1	Cumulative fluid balance, mL	1,664 ± 1,971	3,832 ± 4,291	2,626 ± 3,732	870
	Death, n (%)	1/10 (10%)	1/3 (33.3%)	2/3 (66.6%)	0/1 (0%)	4/17 (23.5%)
Type 2	Cumulative fluid balance, mL	1,566	2,365 ± 2,140	3,935 ± 2,130	5,974 ± 3,144
	Death, n (%)	0/1 (0%)	1/4 (25%)	0/2 (0%)	2/4 (50%)	3/11 (27.3%)
Type 3	Cumulative fluid balance, mL	571	-	1,601 ± 1,147	3,242 ± 3,296
	Death, n (%)	0/1 (0%)	0	1/3 (33.3%)	2/5 (40%)	3/9 (33.3%)
Type 4	Cumulative fluid balance, mL	−1,380 ± 3,308	−1,159 ± 3,394	2,461 ± 2,844	2,613 ± 3,962
	Death, n (%)	3/4 (75%)	1/5 (20%)	1/4 (25%)	14/20 (70%)	19/33 (57.6%)
Total death, n (%)		4/16 (25%)	3/12 (25%)	4/12 (33.3%)	18/30 (60%)	29/70 (41.4%)

Fluid status: type 1, no overhydration and B-type natriuretic peptide (BNP) normal; type 2, no overhydration but BNP abnormal; type 3, overhydration but BNP normal; type 4, overhydration and BNP abnormal. CRRT, continuous renal replacement therapy.

Back to article page

ISSN: 1364-8535

Contact us

Submission enquiries: journalsubmissions@springernature.com